Status:
NOT_YET_RECRUITING
Personalized IoT-based Physical Activity Monitoring System for Heart Failure Patients
Lead Sponsor:
Abant Izzet Baysal University
Conditions:
Heart Failure
Reduced Ejection Fraction Heart Failure
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
Current literature emphasizes the importance of increasing physical activity, ensuring its continuity, and reducing sedentary behaviors in patients with heart failure (HF). Many patients are referred ...
Detailed Description
Globally, the prevalence of HF increases with age, affecting 1-2% of adults in developed countries. In Türkiye, more than one million HF cases were recorded in 2016, with a hospital admission rate of ...
Eligibility Criteria
Inclusion
- Diagnosis of HF confirmed by echocardiographic examination,
- Heart failure characterized by reduced ejection fraction (HFrEF),
- Individuals aged 18-75 years,
- New York Heart Association (NYHA) functional class I, II, or III,
- No evidence of ischemia on coronary angiography performed within the last three months,
- No physical limitations preventing exercise,
- Standardized Mini-Mental State Examination (MMSE) score ≥ 25,
- Ownership of a smartphone compatible with the mobile application to be used in the study.
Exclusion
- Presence of an ischemic lesion requiring revascularization on coronary angiography,
- History of major cardiac surgery within the last three months,
- Worsening dyspnea at rest and exercise intolerance,
- Presence of arrhythmia problems such as ventricular tachyarrhythmia or atrial fibrillation,
- Uncontrolled diabetes (Hemoglobin A1C ≥ 7 mg/dl),
- Presence of chronic pulmonary disease or renal insufficiency,
- Symptomatic postural hypotension (≥20 mmHg systolic drop),
- Score ≥ 9 on the Edmonton Frail Scale (moderate to severe frailty),
- Morbid obesity (BMI \> 40 kg/m²),
- Neuropsychiatric disorders severely impairing cognitive functions such as dementia or Alzheimer's disease,
- Unwillingness to participate in the exercise program.
Key Trial Info
Start Date :
December 13 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 13 2027
Estimated Enrollment :
82 Patients enrolled
Trial Details
Trial ID
NCT07171372
Start Date
December 13 2025
End Date
March 13 2027
Last Update
September 12 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.